PHARMACEUTICAL DRUG DELIVERY MARKET ANALYSIS

Pharmaceutical Drug Delivery Market by Route of administration (Oral Drug Delivery, Topical Drug Delivery, Inhalation Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, and Implantable Drug Delivery), by Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Others), by End Users (Hospitals, Ambulatory Surgical Centers/Clinics, Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI2633
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Increasing approval of new drugs from U.S. FDA is expected to drive growth of the global pharmaceutical drug delivery market. For instance, in April 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Duobrii (contains-halobetasol propionate and tazarotene), which is used for the treatment of plaque psoriasis. It is manufactured by Ortho Dermatogics Company.

Furthermore, new product launches is expected to boost the global pharmaceutical drug delivery market. For instance, in August 2018, Sanofi Genzyme launched new drug (Aubagio) for the treatment of multiple sclerosis. Aubagio offers once-a-day treatment and ease of convenience for the patient.

Moreover, in April 2019, Pfizer launched trastuzumab (trazimera) for the treatment of metastatic HER2 (Human Epidermal Growth Factor 2)-positive breast cancer and HER2-positive metastatic gastric cancer. Hence, these products are expected to boost the global pharmaceutical drug delivery market.

PHARMACEUTICAL DRUG DELIVERY MARKET ANALYSIS

Market News

Pharmaceutical Drug Delivery Market Report Snapshots

EXISTING CLIENTELE